DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 146 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,380,161 | -8.1% | 501,585 | +1.7% | 0.00% | 0.0% |
| Q2 2023 | $6,945,101 | -1.6% | 493,260 | +8.0% | 0.00% | 0.0% |
| Q1 2023 | $7,055,165 | +19.6% | 456,645 | +26.9% | 0.00% | 0.0% |
| Q4 2022 | $5,897,417 | -8.2% | 359,818 | +3.6% | 0.00% | 0.0% |
| Q3 2022 | $6,426,000 | +48.9% | 347,298 | +5.8% | 0.00% | 0.0% |
| Q2 2022 | $4,316,000 | +69.1% | 328,158 | +19.2% | 0.00% | +100.0% |
| Q1 2022 | $2,553,000 | -11.2% | 275,329 | -6.4% | 0.00% | 0.0% |
| Q4 2021 | $2,876,000 | -70.4% | 294,300 | +3.0% | 0.00% | -66.7% |
| Q3 2021 | $9,706,000 | -4.2% | 285,630 | +3.2% | 0.00% | 0.0% |
| Q2 2021 | $10,132,000 | -16.4% | 276,753 | +2.4% | 0.00% | -25.0% |
| Q1 2021 | $12,125,000 | -18.0% | 270,384 | +4.3% | 0.00% | -33.3% |
| Q4 2020 | $14,795,000 | +14.1% | 259,233 | +2.5% | 0.01% | 0.0% |
| Q3 2020 | $12,970,000 | +27.0% | 252,812 | +47.8% | 0.01% | +20.0% |
| Q2 2020 | $10,213,000 | +99.2% | 171,009 | +37.3% | 0.01% | +66.7% |
| Q1 2020 | $5,127,000 | -29.1% | 124,521 | +7.2% | 0.00% | -25.0% |
| Q4 2019 | $7,229,000 | +96.1% | 116,144 | +6.9% | 0.00% | +100.0% |
| Q3 2019 | $3,687,000 | +89.3% | 108,614 | +25.8% | 0.00% | +100.0% |
| Q2 2019 | $1,948,000 | +15.2% | 86,348 | +18.6% | 0.00% | 0.0% |
| Q1 2019 | $1,691,000 | +15.7% | 72,820 | +4.6% | 0.00% | 0.0% |
| Q4 2018 | $1,462,000 | -46.6% | 69,636 | -1.6% | 0.00% | -50.0% |
| Q3 2018 | $2,740,000 | +14.9% | 70,756 | +16.8% | 0.00% | 0.0% |
| Q2 2018 | $2,384,000 | +251.6% | 60,568 | +79.2% | 0.00% | +100.0% |
| Q1 2018 | $678,000 | +6.6% | 33,791 | +20.4% | 0.00% | 0.0% |
| Q4 2017 | $636,000 | – | 28,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |